XCUR Exicure Corp Company Current Liabilities

Exicure (XCUR) - corporate logo

Exicure, Inc. is developing innovative, patent-protected therapies based on spherical nucleic acids. The company's short-term borrowings reflect liability dynamics, with the current level sitting around 0.00. The business relies on a scalable R&D model, monetizing genetic platforms through royalties from pharma behemoths. The asset is currently undergoing a deep restructuring, optimizing its balance sheet and pivoting away from costly clinical trials.

XCUR (Exicure Corp) Short-Term Debt Volume history from 07/04/2022 to 10/30/2026

Summary analytical data breakdowns for Exicure Inc. (XCUR)

- stock price and consensus target price:
Stock Price Exicure Corp|XCUR - Average Forecast Price
- market capitalization data:
Market Valuation Exicure, Inc.|XCUR - Business Value
- balance sheet net asset value indicators:
Book Value per Share Exicure|XCUR - Book Valuation of Business|Market Capitalization to Book Value Ratio exicuretx.com|XCUR - Cumulative Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Exicure, Inc.|XCUR - Long-Term Debt to Capital|Short-Term Debt to Equity Exicure Corp|XCUR - Aggregate Debt Obligations|Debts to Book Capitalization Exicure, Inc.|XCUR - Long-Term Debt|Company Current Liabilities Exicure|Quick Ratio exicuretx.com
- net income and valuation multiples indicators:
XCUR - Net Financial Result
General company analysis:exicuretx.com (XCUR)
Flagship merchandise of Exicure Corp

The development of SNA gene therapy at Exicure, Inc. (XCUR) requires significant investment; therefore, an analysis of short-term liabilities allows for an assessment of the company's liquidity when calculating loan payments. The trend of short-term financial debt on the GURU.Markets platform demonstrates the issuer's ability to settle current liabilities, as excessive borrowing during a period of high interest rates could substantially limit net income and growth rates.

Main competitors

Tempus AI, Inc - Company Short-Term Debts|Short-Term Debt Qiagen NV|IONS (Ionis Pharma) - Company Current Liabilities|Company Short-Term Indebtedness RGEN|RNA (Avidity Biosciences) - Company Short-Term Debts|crisprtx.com (CRSP) - Short-Term Debt Volume|Company Short-Term Debts WGS|Company Current Liabilities Ultragenyx Pharmaceutical Inc. RARE|Beam Therapeutics Corp - Company Current Liabilities|Company Short-Term Debts Sarepta Corp SRPT|TWST - Company Short-Term Debt|Company Short-Term Loans and Borrowings TXG (10xgenomics.com)|NTLA: Company Short-Term Debts|Short-Term Debt Stoke Therapeutics Inc (STOK)|Company Current Liabilities BLFS|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|Short-Term Debt Volume sionnatx.com|Company Short-Term Debt Prime Medicine PRME|TSHA: Company Short-Term Indebtedness|uniQure Corp - Company Short-Term Debts|MeiraGTx Corp (MGTX) - Company Current Liabilities|RGNX (REGENXBIO Inc.) - Company Current Liabilities|SLDB - Short-Term Debt Volume|Company Current Liabilities OCGN|Company Short-Term Indebtedness PACB (Pacific Biosciences of California, Inc.)|Company Short-Term Debts BNTC|Company Current Liabilities Design Corp DSGN|Rocket Pharmaceuticals - Company Current Liabilities|Company Short-Term Debts 4dmoleculartherapeutics.com FDMT|LXEO - Company Short-Term Debt|Company Short-Term Loans and Borrowings KRRO (Korro Bio, Inc.)|EDIT: Company Short-Term Debts|Company Short-Term Indebtedness SLN|Company Short-Term Debt ProQR|Company Short-Term Indebtedness CDXS (Codexis Bio)|Company Short-Term Debts SGMO|Company Short-Term Debts nautilus.bio (NAUT)|Company Short-Term Debts MGX (Metagenomi, Inc)|precisionbiosciences.com (DTIL) - Short-Term Debt|GBIO: Company Current Liabilities|BOLD (boundlessbio.com) - Company Short-Term Indebtedness|IMNN: Company Short-Term Debts|PHIO - Short-Term Debt Volume|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Company Current Liabilities TransCode (RNAZ)|Company Current Liabilities BNGO (Bionano Genomics, Inc.)|Company Short-Term Debts adnas.com (APDN)|Company Short-Term Debt bluebird bio BLUE|Company Short-Term Loans and Borrowings IPA|Omega - Company Short-Term Debts|Short-Term Debt Singular Genomics Corp|RGLS (Regulus Therapeutics) - Company Current Liabilities|syros.com - Company Short-Term Loans and Borrowings|TBIO (Telesis Bio) - Company Short-Term Debts|TRACON Pharmaceuticals Inc. (TCON) - Short-Term Debt Volume|Company Short-Term Debt Unity Bio (UBX)